Disproportionate Short Stature: Deletion/Duplication Panel
Condition Description
Skeletal dysplasias are a heterogeneous group of more than 450 disorders with complex mechanisms. Clinical and biochemical features continue to be used reliably to assign patients to this general disease category. Identification of the precise genetic defect is important; however, to permit carrier testing and early prenatal diagnosis. Molecular analysis is likely to expand the clinical spectrum of skeletal dysplasia and may also provide data relevant to prognosis and future therapeutic intervention.
Collectively, the incidence of skeletal dysplasia is estimated to be 1 in 5,000 births. Skeletal dysplasia is referred to as generalized disorders of cartilage and bone, frequently resulting in disproportionate short stature. A variety of complications can be associated with skeletal dysplasias, including orthopedic, neurologic, auditory, visual, pulmonary, cardiac, renal, and psychological.
References:
Collectively, the incidence of skeletal dysplasia is estimated to be 1 in 5,000 births. Skeletal dysplasia is referred to as generalized disorders of cartilage and bone, frequently resulting in disproportionate short stature. A variety of complications can be associated with skeletal dysplasias, including orthopedic, neurologic, auditory, visual, pulmonary, cardiac, renal, and psychological.
References:
- Alanay and Lachman. (2011) J Clin Res Pediatr Endocrinol. 3(4):163-78.
- Krakow and Rimoin. (2010) Genet Med. 12(6):327-41.
- Orioli, Castilla, and Barbosa-Neto.(1986) J Med Genet.2 3:328-332.
- Seaver and Irons. (2009) Genet Med. 11(6):465-70.
- Warman et al. (2011) Am J Med Genet A. 155A(5):943-68
Genes (76)
ACP5, ANKH, ANO5, B3GALT6, BMPR1B, CANT1, CDKN1C, CHST14, CHST3, COL10A1, COL11A1, COL11A2, COL1A1, COL2A1, COL9A1, COL9A2, COL9A3, COMP, CTSK, CUL7, DDR2, DHCR24, DYM, DYNC2H1, EIF2AK3, EVC, EVC2, EXT1, EXT2, FAM20C, FBN1, FGFR1, FGFR2, FGFR3, FLNA, FLNB, GDF5, GLI3, GPC6, HSPG2, ICK, IFT122, IFT140, IFT80, IHH, KIF22, LIFR, MATN3, MMP13, MMP9, NEK1, NKX3-2, NPR2, OBSL1, PAPSS2, PCNT, PRKAR1A, PTH1R, PTPN11, ROR2, RUNX2, SH3PXD2B, SHOX, SLC26A2, SLC35D1, SLC39A13, SMARCAL1, SOX9, SULF1, TBCE, TCTN3, TRIP11, TRPS1, TRPV4, WDR35, WNT5A
Your search may have returned a result for a gene alias. Click here for a full list of genes and their aliases.
Indications
This test is indicated for:
- Short stature with abnormal radiographic findings.
Methodology
Deletion/Duplication Analysis: DNA isolated from peripheral blood is hybridized to a gene-targeted CGH array to detect deletions and duplications. The targeted CGH array has overlapping probes that cover the entire genomic region.
Detection
Deletion/Duplication Analysis: Detection is limited to duplications and deletions. The CGH array will not detect point or intronic mutations. Results of molecular analysis must be interpreted in the context of the patient's clinical and/or biochemical phenotype.
Specimen Requirements
When sample fails to meet the acceptable criteria, please call 470.378.2200 and ask to speak with a laboratory genetic counselor (eglgc@egl-eurofins.com).
Submit only 1 of the following specimen types
Whole Blood (EDTA)
WBP
Requirements
EDTA (Purple Top)
Infants and Young Children (<2 years of age): 2-3 ml
Children > 2 years of age to 10 years old: 3-5 ml
Older Children & Adults: 5-10 ml
Autopsy: 2-3 ml unclotted cord or cardiac blood
Infants and Young Children (<2 years of age): 2-3 ml
Children > 2 years of age to 10 years old: 3-5 ml
Older Children & Adults: 5-10 ml
Autopsy: 2-3 ml unclotted cord or cardiac blood
Collection and Shipping
Ship sample at room temperature for receipt at EGL within 24 hours of collection. Do not refrigerate or freeze.
DNA, Isolated
DNA
Requirements
Microtainer
3µg
Isolation using the Perkin Elmer™Chemagen™ Chemagen™ Automated Extraction method or Qiagen™ Puregene kit for DNA extraction is recommended.
3µg
Isolation using the Perkin Elmer™Chemagen™ Chemagen™ Automated Extraction method or Qiagen™ Puregene kit for DNA extraction is recommended.
Collection and Shipping
Refrigerate until time of shipment in 100 ng/µL in TE buffer. Ship sample at room temperature with overnight delivery.
Special Instructions
Please include radiographic findings for expert review at EGL Genetics.
Related Tests
- Disproportionate Short Stature: Sequencing Panel
- Skeletal Dysplasia: Sequencing Panel